Penn Center for Research on Coronavirus and Other Emerging Pathogens

In response to the global SARS-CoV-2 crisis, and in close consultation with leadership of the Perelman School of Medicine, we are excited to announce the founding of the Penn Center for Research on Coronaviruses and Other Emerging Pathogens.

The goals of the Center are to 1) Accelerate SARS-CoV-2 research under Biosafety Level 3 containment, 2) Provide centralized information on SARS-CoV-2 research at Penn, and 3) Compile information on funding opportunities for research on SARS-CoV-2 and other emerging pathogens.

The Center will be led by Susan Weiss and Frederic Bushman. A highly distinguished set of researchers from Penn, CHOP and Wistar have agreed to serve as our internal advisory board.

Already Penn researchers are expanding stocks of SARS-CoV-2 and beginning studies of viral replication and inhibition. The Center is working to expand these efforts and to create new research opportunities in this area.

It is gratifying to see how rapidly the Penn community has come together to address this global health crisis. We have much to do.

Internal Advisory Board

Funding Sources

Papers on Coronaviruses from the Penn Community

Join our listserv and tell us about your research project!

DONATE NOW

ANNOUNCEMENTS

A single and two-stage, closed-tube, molecular test for the 2019 novel coronavirus at home, clinic, and points of entry, El-Tholoth, Bau and Song, in “ChemRxiv”

No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2, Liu, Saif, Weiss and Su, “Emerging Microbes and Infections”

TWITTER

.@PennMedicine researchers found that more than 1/3 of samples taken from recent #COVID19 cases in the Philadelphia area were caused by viral variants, underscoring the importance of continued public health measures😷 ft. @bushmanlab (@PennMicro/ @PENNCoV) https://bit.ly/3sOQuCh

More than a third of recent COVID-19 samples from Philadelphia-area patients were caused by variants, according to a new analysis from the @bushmanlab. “So it’s a battle that’s right on the edge,” said @PennMicro Chair Frederic Bushman, PhD.
https://www.inquirer.com/health/coronavirus/covid-19-worrisome-variants-challenge-vaccination-progress-and-relaxed-precautions-20210330.html

Check out this exciting COVID-19 airway microbiome study on MedRxiv! I'm lucky to have had a small part in this preprint. Great work @CMerenstein @bushmanlab and everyone involved! https://twitter.com/CMerenstein/status/1379131370740588550

Learn about the human virome in this review from @bushmanlab & @GuanxiangL #virome https://twitter.com/NatureRevMicro/status/1376931616594006019

Excited to see the @bushmanlab COVID-19 airway microbiome manuscript on MedRxiv! Here's some of what we found:

https://www.medrxiv.org/content/10.1101/2021.04.02.21254514v1


Member Login